Praxis Precision Medicines, Inc. (PRAX)
NASDAQ: PRAX · Real-Time Price · USD
252.76
-6.16 (-2.38%)
Oct 23, 2026, 4:00 PM EDT - Market closed
PRAX Market Cap
PRAX has a market cap or net worth of $7.06 billion as of October 23, 2026. It is the 2,698th most valuable company in the world and the 920th biggest in the United States. Its market cap has increased by 54.96% in one year.
Market Cap
7.06B
Enterprise Value
5.68B
1-Year Change
54.96%
Global Rank
Country Rank
#920 United States
Category
ChartMarket Cap Chart
Since the IPO on October 16, 2020, PRAX's market cap has increased from $698.02M to $7.06B, an increase of 911.01%. That is a compound annual growth rate of 46.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 7.06B | -4.25% |
| Dec 31, 2025 | 7.37B | 397.55% |
| Dec 31, 2024 | 1.48B | 675.84% |
| Dec 29, 2023 | 190.94M | 70.27% |
| Dec 30, 2022 | 112.14M | -87.31% |
| Dec 31, 2021 | 883.49M | -58.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cytokinetics | 8.74B |
| Spyre Therapeutics | 8.69B |
| ABIVAX Société Anonyme | 8.33B |
| Arrowhead Pharmaceuticals | 8.31B |
| Axsome Therapeutics | 8.19B |
| TG Therapeutics | 7.55B |
| Ionis Pharmaceuticals | 7.36B |
| Iovance Biotherapeutics | 6.62B |